Recent results have shown that CD133 may interact with the regulatory subunit of PI3K, stabilizing AKT signalling and conferring CSC‐like properties to hepatocellular carcinoma (Jang et al., 2017a,2017b). The gene discussed is PROM1; the disease is hepatocellular carcinoma.